ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 98 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $293,218 | -30.9% | 125,844 | +32.7% | 0.00% | – |
Q1 2024 | $424,032 | +60.8% | 94,862 | +15.5% | 0.00% | – |
Q4 2023 | $263,721 | +2.3% | 82,156 | +1.0% | 0.00% | – |
Q3 2023 | $257,749 | -32.8% | 81,309 | +5.3% | 0.00% | – |
Q2 2023 | $383,715 | +0.6% | 77,206 | 0.0% | 0.00% | – |
Q1 2023 | $381,397 | -18.6% | 77,206 | +3.6% | 0.00% | – |
Q4 2022 | $468,757 | -40.7% | 74,524 | +1.9% | 0.00% | – |
Q3 2022 | $790,000 | -8.0% | 73,142 | -3.0% | 0.00% | – |
Q2 2022 | $859,000 | +51.8% | 75,372 | +21.3% | 0.00% | – |
Q1 2022 | $566,000 | -38.9% | 62,141 | +0.2% | 0.00% | – |
Q4 2021 | $926,000 | -41.9% | 62,029 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $1,593,000 | +66.1% | 62,029 | +68.7% | 0.00% | – |
Q2 2021 | $959,000 | -27.1% | 36,768 | -1.3% | 0.00% | – |
Q1 2021 | $1,316,000 | +91.6% | 37,266 | +36.9% | 0.00% | – |
Q4 2020 | $687,000 | -33.2% | 27,227 | -0.2% | 0.00% | – |
Q3 2020 | $1,029,000 | -16.5% | 27,279 | -5.2% | 0.00% | -100.0% |
Q2 2020 | $1,232,000 | +148.4% | 28,762 | +12.9% | 0.00% | – |
Q1 2020 | $496,000 | -29.7% | 25,473 | -6.3% | 0.00% | – |
Q4 2019 | $706,000 | +33.2% | 27,176 | +39.7% | 0.00% | – |
Q3 2019 | $530,000 | +1.5% | 19,447 | 0.0% | 0.00% | – |
Q2 2019 | $522,000 | -82.3% | 19,447 | -80.9% | 0.00% | -100.0% |
Q1 2019 | $2,947,000 | +3211.2% | 102,030 | +2983.4% | 0.00% | – |
Q4 2018 | $89,000 | – | 3,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |